Log In
Print
BCIQ
Print
Print this Print this
 

RDX009

  Manage Alerts
Collapse Summary General Information
Company Ardelyx Inc.
DescriptionG protein-coupled bile acid receptor 1 (GPBAR1; TGR5) agonist
Molecular Target G protein-coupled bile acid receptor 1 (GPBAR1) (TGR5)
Mechanism of Action 
Therapeutic ModalitySmall molecule
Latest Stage of DevelopmentPreclinical
Standard IndicationInflammatory bowel disease (IBD)
Indication DetailsTreat inflammatory bowel disease (IBD)
Regulatory Designation

Partner


 Product Details
 Archive Items are loading loading
Get a free BioCentury trial today